Insight

Dec 11, 2024, 09:53

Thomas Powles was appointed Editor-in-Chief of Annals of Oncology

Thomas Powles recently joined Annals of Oncology as Editor-in-Chief.

Editor-in-Chief

Thomas Powles, specializing in urology cancer, holds the position of Professor at the University of London since 2012 and serves as the Director of Barts Cancer Centre, a CRUK Major Cancer Centre. With a role in biomarker development and drug strategies, he has secured multiple EMA and FDA approvals.

His achievements include advancing front-line immune/targeted therapy combinations in RCC and immune checkpoint inhibition in bladder cancer. He completed his education from Queen Mary University of London.

Fabrice André was the previous Editor-in-Chief of Annals of Oncology.

Editor-in-Chief

Fabrice André is a prominent medical oncologist specializing in breast cancer.

He holds the position of Director of the Research Division at Gustave Roussy Cancer Center and Professor of Medicine at the University Paris Saclay.

Professor André also chairs the biomarker group at UNICANCER (the French cooperative group). He is the President-Elect of the European Society for Medical Oncology (ESMO).

Annals of Oncology is a leading, peer-reviewed medical journal focused on the field of oncology.

Editor-in-Chief

Published by Elsevier, it is the official journal of the European Society for Medical Oncology (ESMO). The journal has been in publication since 1990 and provides a platform for high-quality research, reviews, and clinical studies related to cancer treatment, prevention, and care.

Published monthly in English, Annals of Oncology has a hybrid open-access model, allowing some articles to be freely accessible to the public. With an impact factor of 32.976 (as of 2020), the journal is one of the most influential in the oncology field. It is indexed by several databases and offers both print (ISSN 0923-7534) and online (ISSN 1569-8041) access.

Before its current publisher, Elsevier, the journal was previously published by Oxford University Press and Springer.